In this context, all the thrombolytic agents in current therapeutic use for deep vein thrombosis (DVT) e.g., the variants of tissue type plasminogen activator (tPA) are plasminogen activators (PAs). The gene discussed is PLAT; the disease is deep vein thrombosis.